Batu Biologics Appoints Dr. Santosh Kesari To Scientific Advisory Board

Batu Biologics, an immuno-oncology company based out of San Diego dedicated to the development of its polyvalent tumor endothelium vaccine, ValloVax, announced today the appointment of Santosh Kesari, MD, PhD, FANA to its scientific advisory board. Batu Biologics has recently filed an Investigational New Drug (IND) application with the FDA seeking to initiate a Phase I dose-escalation study for ValloVax in patients with non-small cell lung cancer.

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.